RainDance Technologies Inc., is a provider of innovative microdroplet-based solutions for human health and disease research, initially in the fields of genomics and molecular epidemiology. The company’s product line includes RDT 1000 Research Screening Panels, ASDSeq™ panel, XSeq™ panel, HLASeq™ panel and Sequence Enrichment Consumables Kits. The company’s RainStorm™ microfluidics technology produces 10 million picoliter-volume droplets per hour. The company’s solutions will be offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world. RainDance’s initial application will focus on the targeted sequencing of the human genome, one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology. The company’s investors include Mohr Davidow Ventures, Alloy Ventures, Acadia Woods, LLC and Quaker BioVentures. RainDance Technologies collaborates with world-renowned organizations to develop and market applications for its innovative RainStorm™ microdroplet-based technology.